| Gregory B Parranto, MD | |
|
1550 N Main St, Lima, OH 45801-2823 | |
| (419) 516-0327 | |
| (419) 225-8878 |
| Full Name | Gregory B Parranto |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 22 Years |
| Location | 1550 N Main St, Lima, Ohio |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1447238993 | NPI | - | NPPES |
| 2545375 | Medicaid | OH | |
| 000000527466 | Other | OH | ANTHEM BLUE CROSS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 35084130 (Ohio) | Secondary |
| 207Q00000X | Family Medicine | 35-08-4130 (Ohio) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Heritage Health Care Services | Maumee, OH | Home health agency |
| Mercy Health-st Rita's Medical Center | Lima, OH | Hospital |
| Lima Memorial Health System | Lima, OH | Hospital |
| Carecore At Lima Llc | Lima, OH | Nursing home |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Encompass Care, Inc. | 2062752595 | 19 |
| Mercy Health Physicians Lima Specialty Care Llc | 7012332364 | 204 |
| Health Partners Of Western Ohio | 9436139987 | 41 |
News Archive
PROLOR Biotech, Inc., a company developing next generation biobetter therapeutic proteins, today announced initiation of a Phase II clinical trial of hGH-CTP, the company's proprietary biobetter version of human growth hormone (hGH).
Shire plc, the global specialty biopharmaceutical company, announces that the U.S. Court of Appeals for the District of Columbia Circuit has affirmed the ruling of the U.S. District Court for the District of Columbia and the U.S. Food and Drug Administration to grant five-year New Chemical Entity exclusivity to lisdexamfetamine dimesylate, currently marketed by Shire U.S. Inc. under the name VYVANSE(R).
Today, The Endocrine Society released "Evaluation, Treatment, and Prevention of Vitamin D Deficiency: An Endocrine Society Clinical Practice Guideline." The clinical practice guideline (CPG) is published in the July 2011 issue of the Journal of Clinical Endocrinology & Metabolism (JCEM), a publication of The Endocrine Society.
The powerful chemotherapy and radiation used to save cancer patients' lives can also destroy their fertility.
› Verified 9 days ago
| Entity Name | Health Partners Of Western Ohio |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760952741 PECOS PAC ID: 9436139987 Enrollment ID: O20150313002043 |
News Archive
PROLOR Biotech, Inc., a company developing next generation biobetter therapeutic proteins, today announced initiation of a Phase II clinical trial of hGH-CTP, the company's proprietary biobetter version of human growth hormone (hGH).
Shire plc, the global specialty biopharmaceutical company, announces that the U.S. Court of Appeals for the District of Columbia Circuit has affirmed the ruling of the U.S. District Court for the District of Columbia and the U.S. Food and Drug Administration to grant five-year New Chemical Entity exclusivity to lisdexamfetamine dimesylate, currently marketed by Shire U.S. Inc. under the name VYVANSE(R).
Today, The Endocrine Society released "Evaluation, Treatment, and Prevention of Vitamin D Deficiency: An Endocrine Society Clinical Practice Guideline." The clinical practice guideline (CPG) is published in the July 2011 issue of the Journal of Clinical Endocrinology & Metabolism (JCEM), a publication of The Endocrine Society.
The powerful chemotherapy and radiation used to save cancer patients' lives can also destroy their fertility.
› Verified 9 days ago
| Entity Name | Mercy Health Physicians Lima Specialty Care Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1518589803 PECOS PAC ID: 7012332364 Enrollment ID: O20200803002433 |
News Archive
PROLOR Biotech, Inc., a company developing next generation biobetter therapeutic proteins, today announced initiation of a Phase II clinical trial of hGH-CTP, the company's proprietary biobetter version of human growth hormone (hGH).
Shire plc, the global specialty biopharmaceutical company, announces that the U.S. Court of Appeals for the District of Columbia Circuit has affirmed the ruling of the U.S. District Court for the District of Columbia and the U.S. Food and Drug Administration to grant five-year New Chemical Entity exclusivity to lisdexamfetamine dimesylate, currently marketed by Shire U.S. Inc. under the name VYVANSE(R).
Today, The Endocrine Society released "Evaluation, Treatment, and Prevention of Vitamin D Deficiency: An Endocrine Society Clinical Practice Guideline." The clinical practice guideline (CPG) is published in the July 2011 issue of the Journal of Clinical Endocrinology & Metabolism (JCEM), a publication of The Endocrine Society.
The powerful chemotherapy and radiation used to save cancer patients' lives can also destroy their fertility.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Gregory B Parranto, MD 329 N West St, Lima, OH 45801-4332 Ph: (419) 221-3072 | Gregory B Parranto, MD 1550 N Main St, Lima, OH 45801-2823 Ph: (419) 516-0327 |
News Archive
PROLOR Biotech, Inc., a company developing next generation biobetter therapeutic proteins, today announced initiation of a Phase II clinical trial of hGH-CTP, the company's proprietary biobetter version of human growth hormone (hGH).
Shire plc, the global specialty biopharmaceutical company, announces that the U.S. Court of Appeals for the District of Columbia Circuit has affirmed the ruling of the U.S. District Court for the District of Columbia and the U.S. Food and Drug Administration to grant five-year New Chemical Entity exclusivity to lisdexamfetamine dimesylate, currently marketed by Shire U.S. Inc. under the name VYVANSE(R).
Today, The Endocrine Society released "Evaluation, Treatment, and Prevention of Vitamin D Deficiency: An Endocrine Society Clinical Practice Guideline." The clinical practice guideline (CPG) is published in the July 2011 issue of the Journal of Clinical Endocrinology & Metabolism (JCEM), a publication of The Endocrine Society.
The powerful chemotherapy and radiation used to save cancer patients' lives can also destroy their fertility.
› Verified 9 days ago
Dr. Surinder K Bansal, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 658 W Market St, Lima, OH 45801 Phone: 419-222-3386 Fax: 419-224-7716 | |
Madeline Agosto, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 915 W Market St, Lima, OH 45805 Phone: 419-229-4747 Fax: 419-224-3348 | |
Mark T Mueller, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2745 Fort Amanda Rd, Lima, OH 45805 Phone: 419-996-5700 Fax: 419-996-5639 | |
Amy Sue Hovest, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 730 W Market St, Lima, OH 45801 Phone: 419-226-4310 Fax: 419-226-4315 | |
Dr. Salim W Hanna, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1005 Bellefontaine Ave Ste 340, Lima, OH 45804 Phone: 419-227-3077 Fax: 419-224-1667 | |
Pooja Gupta, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 730 W Market St, Lima, OH 45801 Phone: 248-346-2340 | |
Dr. Matthew Robert Flaherty, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 830 W High St Ste 390, Lima, OH 45801 Phone: 419-996-1366 Fax: 419-226-9311 |